[Asia Economy Reporter Yoo Hyun-seok] Midas AI is showing strong performance. It appears to be influenced by the news of a 12 billion KRW supply contract for specimen collection kits with Philosis Healthcare.


As of 10:01 AM on the 14th, Midas AI was traded at 848 KRW, up 6.00% (48 KRW) compared to the previous trading day.


The fact that Midas AI holds the overseas distribution rights for some regions of the specimen collection kits sold by Philosis Healthcare has been highlighted. Philosis Healthcare announced on the 13th that it signed a 12 billion KRW supply contract for COVID-19 specimen collection kits.


On the 28th of last month, Midas AI signed an exclusive distribution rights contract with Philosis for specimen collection kits and COVID-19 diagnostic kits in Africa and Brazil.


Hot Picks Today

About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column] About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]

A Midas AI official stated, “The large-scale supply contract for Philosis specimen collection kits is proof of their recognized excellent quality,” adding, “Since specimen collection kits are known to greatly affect the accuracy of diagnostic kits, interest is expected to increase in Brazil and Africa, where we have secured distribution rights.”


한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing